Diligence memo · auto-generated · as of July 2, 2026
Thyme Care, Inc.
Thyme Care, Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
Thyme Care, Inc. operates in Healthtech, based in Nashville.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Thyme Care, Inc. has raised $214M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $97M on 2025-04-04.
Most recent recorded round closed around 2025-04-04.
Valuation (modeled)modeled
Provath models Thyme Care, Inc. at approximately $668M (range $353M–$915M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.02× the median modeled value of Series C Healthtech companies in 2025–2027 (19 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 15 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 1.8× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 98% of Healthtech peers (2138 compared).
Modeled value ranks above 95% of those peers.
Closest niche peers: Cohere Health Inc., All Inspire Health, Inc., Harbor Health Team Inc., Apreo Health, Inc., 4C Medical Technologies, Inc..
Peoplefiled
13 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.